MEHMET ALİ AYDINLAR
Chairman of the Board
Beginning his career as a financial advisor in 1981, Mr. Aydınlar stepped into the health sector with Acıbadem Hospital in 1991. In 1998, he was granted the award “Excellence in Management” at the World Young Entrepreneur Competition. He received the title of Honorary Doctorate from Dumlupınar University Institute of Social Sciences. In 2006, he was selected the “Male Entrepreneur of the Year” in Economist Magazine's survey “Business Person of the Year” and “Business Manager of the Year” by Dünya Newspaper and İstanbul University Faculty of Business. The same year, the newspaper Referans selected Acıbadem Hospitals Group as “Turkey's Fastest Fish”. Mr. Aydınlar was deemed worthy of the award “Person Who Makes Most Voluntary Personal Contributions to Healthcare” by Health Volunteers Foundation Turkey in years 2007, 2009 and 2010. In 2008, he received the “Healthcare Management Honorary Award” from Hospital News Maganize. In addition to the “Outstanding Service Award” of Turkish Parliament, Mr. Aydınlar also received the “Sportsman of the Year” award in 2011 for his contributions to sports.
HATİCE SEHER AYDINLAR
Vice Chairman of the Board
Hatice Seher Aydınlar graduated from Chemistry Faculty of Galatasaray University. She entered the health sector with a position at Acıbadem Hospital in 1993. Ms. Aydınlar currently serves as a Vice Chairman of the Board in Acıbadem Hospitals Group.
DR. KELVIN LOH CHI KEON
Dr. Kelvin Loh Chi-Keon, serving as the Chief Executive Officer ("CEO") and Executive Director of IHH Healthcare Berhad ("IHH”), was appointed as a Board Member for ASH and ASYH. Meanwhile, he was also appointed as the Vice Chairman of the Board for APlus and APY on October 1st 2019.
Dr. Loh started his career as a practicing physician after a decade in the public sector in areas such as clinical services development, hospital planning and hospital operations. Dr. Loh first joined the IHH Group in 2008. Between 2008 and 2017, he held a number of senior management roles, before taking over as CEO for its Singapore Operations Division, covering among other services, the 4 multi-specialty tertiary hospitals - Mount Elizabeth Orchard, Mount Elizabeth Novena, Gleneagles and Parkway East.
In 2017, Dr. Loh moved to Columbia Asia Group as CEO where he was responsible for overseeing Columbia Asia Group's 28 hospitals across 4 countries in Asia, before he rejoined IHH.
With more than 20 years' experience in the healthcare industry and a strong track record of delivery, Dr. Loh is a senior healthcare executive with extensive experience in leading large healthcare businesses, building relationships with stakeholders, managing hospital operations, financial management and developing talent.
An expert in lean management systems, Dr. Loh was previously a member of Singapore's National Expert Advisory Panel for Healthcare Productivity and Advisor to the Asia Productivity Organisation. Dr. Loh was also a Visiting Lecturer for the Master of Public Health and Master of Business Administration programmes at the National University of Singapore.
BHAGAT CHINTAMANI ANIRUDDHA
Member of Board
Mr Bhagat Chintamani Aniruddha ("Mr Chinta Bhagat") is currently an Executive Director in the Investments Division of Khazanah Nasional Berhad ("Khazanah"). He leads the Mumbai office and is the overseeing executive director for the healthcare sector.
Prior to joining Khazanah, Mr Chinta Bhagat spent fourteen (14) years at McKinsey & Company in Singapore, including six (6) years as Managing Partner for the Singapore office. Mr Chinta Bhagat was a leader in the Principal Investor practice, serving several sovereign wealth funds, private equity firms, and family owned businesses; as well as a leader in the healthcare practice, serving hospital systems across Asia. Mr Chinta Bhagat also founded and led McKinsey 's corporate governance service line.
Prior to joining McKinsey, Mr Chinta Bhagat held various positions at an engineering and construction firm in India, culminating in his role as CEO. Mr Chinta Bhagat is also a qualified architect.He graduated Master of Business Administration, INSEAD Business School.
Member of Board
Takeshi Saito (45), was appointed as Board Member as of May 2017. He obtained his Bachelor degree in Political Science from Keio University, Japan and his MBA from Kellogg School of Management Northwestern University. Mr. Saito began his professional career at Mitsui in 1995 and has spent most of his time in healthcare. After spending 2 years in the Finance Division, he became the Director of Pharmaceutical Dept., Life Science Division where he led the Pharmaceutical business. During his tenure at Mitsui USA, he led the initiative to form a new healthcare department at Mitsui USA and subsequently took charge of an investment made in a leading physician revenue cycle and practice management company in the USA. After finishing his MBA in 2004, he was appointed as director of Corporate Planning Dept., Mitsui USA where he was responsible for Chemicals, Natural Resources, Consumer Service and IT Business. In 2007, he became Manager of Strategic Planning/Business Development Department of Life Science Div at Mitsui which subsequently became Medical Healthcare Div in 2008, where he was responsible for the process of managing the department and the investment in one of the Largest Pharmacy Chains in Japan. In 2009, he became director of Medical Healthcare Business Dept., Mitsui & Co., Ltd. where he led the investment in IHH where later he was seconded as VP Strategic Planning, Parkway Group Healthcare.After his secondment at Parkway Group Healthcare, he became General Manager, Provider Network Dept., Medical Healthcare Business Div I, Consumer Service Business Unit, Mitsui & Co., Ltd.
SHIRISH MORESHWAR APTE
Member of Board
Shirish Moreshwar Apte has extensive experience in banking and finance. He began his career in banking with Citibank, India in 1981. He held numerous assignments with Citibank/Citigroup in London (1993-1997), Poland (1997-2003), London (2003-2009), Hong Kong (2009-2011) and Singapore (2011-2013). During his 32 year career with Citibank/Citigroup, Mr. Apte worked in the Emerging Markets covering Central and Eastern Europe, Middle East, Africa (CEEMEA) and Asia Pasific. He was head of Citi's Corporate and Investment bank in India, CEO for Citibank Poland, and regional CEO first for CEEMEA and then Asia Pasific. Mr. Apte was a member of Citigroup's Executive and Operating committees from 2008-2012 and the Group's Business Practices committee. Mr. Apte retired from Citigroup in 2014 as Chairman Asia Pasific banking. He currently serves on several Boards of Directors including Citibank Japan Ltd, Commonwealth Bank of Australia, Institute of Banking and Finance Singapore, India and the Supervisory Board of Bank Handlowy, Poland.
Member of Board
Mustafa Eröğüt completed his undergraduate degree in Business Administration, Management Concentration and his Master’s degree in Sports Management Concentration from Ithaca College, USA. He has actively been appointed to senior sports management posts over the last eight years and continues to develop social responsibility projects. Eröğüt began his career as Administrative Co-ordinator of the Youth Development Academy at Istanbul Metropolitan Municipality (IBB) after which he was appointed IBB Professional Football Team Administrative Manager, Audit Assistant at Baker Tilly Güreli, and Acting Director of the Football Development Department followed by Deputy Director-General of Football of the Turkish Football Federation. Eröğüt continues to hold the posts of Executive Director of Istanbul Başakşehir Football Club and the Deputy Secretary-General of the Turkish Union of Clubs. He is also a member of the UEFA Youth and Amateur Football Committee.
LOW SOON TECK
Member of Board
Low Soon Teck, practised as a solicitor in Singapore at a boutique firm from 1991 to 1993, focusing on corporate and banking laws. Mr Low then joined the Kuok/Kerry Group in 1994, based in Hong Kong holding various senior positions in different businesses within the Kuok/Kerry Group including as the Director of China Operations at SCMP Group, publisher of the South China Morning Post, where he was responsible for business development, newspaper publishing and circulation operations, and managing a chain of retail convenience stores.Mr Low relocated to Singapore in 2005, as the Group Financial Controller of Kuok Oils and Grain Pte Ltd, which was subsequently merged with Wilmar International Limited in 2006. At Wilmar International Limited, he held the position of Group Treasurer until 2009. He was then appointed Chief Financial Officer of PACC Offshore Services Holdings Group, the offshore marine arm of the Kuok/ Kerry Group. In 2013, he joined RCMA Group, a commodities supply chain management company as Chief Financial Officer, a position that he held until 2015. He has over 20 years of experience in finance, legal and general management at leadership roles. Mr Low assumed the position of Group Chief Financial Officer of IHH Healthcare Berhad on 10 January 2016.He graduated Bachelor of Laws (Hons)(2nd Upper), National University of Singapore and Master of Business Adminstration, University of Chicago, Booth School of Business.
ROSSANA ANNIZAH BINTI AHMAD RASHID
Member of Board
Appointed to the Board of IHH Healthcare Berhad ("IHH") in 2012, Ms Rossana Annizah binti Ahmad Rashid also serves on the Board and Board Committee of Acibadem Saglik Yatirimlari Holding A.S., an indirect subsidiary of IHH. She is also a Non- Executive Director of Parkway Trust Management Limited ("PTM"), an indirect wholly-owned subsidiary of IHH. PTM manages Parkway Life Real Estate Investment Trust which is listed on the Singapore Exchange Securities Trading Limited.
Ms Rossana currently serves as the Deputy Chairman on the Board of Cycle & Carriage Bintang Berhad, a member of the Jardine Matheson Group, as Non-Independent Non-Executive Director subsequent to her appointment as Country Chairman of the Jardine Matheson Group of Companies in Malaysia in 2016. Concurrently, she also serves as a member of the Investment Panel and the Investment Panel Risk Committee of Malaysia's Employees Provident Fund. In May 2017, she was appointed as an Independent Non-Executive Director of Celcom Axiata Berhad.